JMP Securities upgraded shares of Ariad Pharmaceuticals (NASDAQ:ARIA) from a market perform rating to an outperform rating in a research report sent to investors on Friday morning, TheFlyOnTheWall.com reports. Ariad Pharmaceuticals (NASDAQ:ARIA) opened at 6.43 on Friday. Ariad Pharmaceuticals has a one year low of $2.15 and a one year high of $23.00. The stock’s […]
JMP Securities Upgrades Ariad Pharmaceuticals to Outperform (ARIA) is a post from: Zolmax
The post JMP Securities Upgrades Ariad Pharmaceuticals to Outperform (ARIA) appeared first on Zolmax.